Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice
Authors
Keywords
-
Journal
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
Volume 66A, Issue 2, Pages 191-201
Publisher
Oxford University Press (OUP)
Online
2010-10-26
DOI
10.1093/gerona/glq178
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001–2004
- (2010) Alison M. Mondul et al. CANCER CAUSES & CONTROL
- Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial
- (2010) Teemu J. Murtola et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau
- (2010) Antonella Caccamo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1
- (2010) Michelle Pacholec et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
- (2010) Patricia Spilman et al. PLoS One
- Different dietary restriction regimens extend lifespan by both independent and overlapping genetic pathways inC. elegans
- (2009) Eric L. Greer et al. AGING CELL
- Statins for the Prevention and Treatment of Infections
- (2009) Imad M. Tleyjeh ARCHIVES OF INTERNAL MEDICINE
- The TOR pathway comes of age
- (2009) Monique N. Stanfel et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Novel Agents on the Horizon for Cancer Therapy
- (2009) W. W. Ma et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Optimal targeting of the mTORC1 kinase in human cancer
- (2009) Heidi A Lane et al. CURRENT OPINION IN CELL BIOLOGY
- Targeting the mTOR pathway using deforolimus in cancer therapy
- (2009) Devalingam Mahalingam et al. Future Oncology
- Targeting the mTOR Signaling Network for Cancer Therapy
- (2009) Funda Meric-Bernstam et al. JOURNAL OF CLINICAL ONCOLOGY
- Life-Span Extension in Mice by Preweaning Food Restriction and by Methionine Restriction in Middle Age
- (2009) L. Sun et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- A midlife longevity drug?
- (2009) Matt Kaeberlein et al. NATURE
- Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span
- (2009) C. Selman et al. SCIENCE
- mTOR Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells
- (2009) C. Chen et al. Science Signaling
- Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice
- (2008) Randy Strong et al. AGING CELL
- Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life Span
- (2008) Kevin J. Pearson et al. Cell Metabolism
- Deforolimus (AP23573) a novel mTOR inhibitor in clinical development
- (2008) Monica Mita et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started